Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

Albendazole introduced in the U.S. for two parasitic infections

Oct. 18, 1996

Glaxo Wellcome claims antiviral agents with RNA virus specificity

Oct. 18, 1996

RiboGene receives grant for antiviral compounds based on PKR

Oct. 18, 1996

Antimicrobial collaboration between Human Genome Sciences and Pharmacia & Upjohn

Oct. 18, 1996

Neuprex enters pivotal trials

Oct. 18, 1996

Bristol-Myers Squibb obtains rights to Kyorin antibiotic

Oct. 18, 1996

Pfizer discloses polycyclic ether antibiotics

Oct. 18, 1996

IND filed for MiKasome

Oct. 11, 1996

Genes associated with latent CMV infection discovered

Oct. 11, 1996

Azole antifungals reported by Takeda

Oct. 11, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 20, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 20, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...